BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gross B, Grebe M, Wencker M, Stoller JK, Bjursten LM, Janciauskiene S. New Findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy. Dermatology. 2009;218:370-375. [PMID: 19218787 DOI: 10.1159/000202982] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Ordóñez A, Harding HP, Marciniak SJ, Ron D. Cargo receptor-assisted endoplasmic reticulum export of pathogenic α1-antitrypsin polymers. Cell Rep 2021;35:109144. [PMID: 34010647 DOI: 10.1016/j.celrep.2021.109144] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Henao MP, Craig TJ. Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency. Expert Rev Respir Med 2016;10:1281-94. [PMID: 27771979 DOI: 10.1080/17476348.2016.1249851] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
3 Stoller JK, Aboussouan LS. A review of α1-antitrypsin deficiency. Am J Respir Crit Care Med. 2012;185:246-259. [PMID: 21960536 DOI: 10.1164/rccm.201108-1428CI] [Cited by in Crossref: 253] [Cited by in F6Publishing: 94] [Article Influence: 25.3] [Reference Citation Analysis]
4 Vignaud H, Cullin C, Bouchecareilh M. [Alpha-1 antitrypsin deficiency: A model of alteration of protein homeostasis or proteostasis]. Rev Mal Respir 2015;32:1059-71. [PMID: 26386628 DOI: 10.1016/j.rmr.2015.05.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
5 Blanco I, Lara B, de Serres F. Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema. Orphanet J Rare Dis 2011;6:14. [PMID: 21486454 DOI: 10.1186/1750-1172-6-14] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
6 Dunlea DM, Fee LT, McEnery T, McElvaney NG, Reeves EP. The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals. J Inflamm Res 2018;11:123-34. [PMID: 29618937 DOI: 10.2147/JIR.S156405] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 4.7] [Reference Citation Analysis]
7 Ekeowa UI, Freeke J, Miranda E, Gooptu B, Bush MF, Pérez J, Teckman J, Robinson CV, Lomas DA. Defining the mechanism of polymerization in the serpinopathies. Proc Natl Acad Sci U S A 2010;107:17146-51. [PMID: 20855577 DOI: 10.1073/pnas.1004785107] [Cited by in Crossref: 112] [Cited by in F6Publishing: 93] [Article Influence: 10.2] [Reference Citation Analysis]
8 Fiehn C. Eine seltene Ursache einer schweren Pannikulitis. Z Rheumatol 2017;76:166-9. [DOI: 10.1007/s00393-016-0247-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Gooptu B, Dickens JA, Lomas DA. The molecular and cellular pathology of α₁-antitrypsin deficiency. Trends Mol Med 2014;20:116-27. [PMID: 24374162 DOI: 10.1016/j.molmed.2013.10.007] [Cited by in Crossref: 76] [Cited by in F6Publishing: 62] [Article Influence: 9.5] [Reference Citation Analysis]
10 Campos MA, Lascano J. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy. Ther Adv Respir Dis 2014;8:150-61. [PMID: 25013223 DOI: 10.1177/1753465814542243] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
11 Nyon MP, Gooptu B. Therapeutic targeting of misfolding and conformational change in α 1 -antitrypsin deficiency. Future Medicinal Chemistry 2014;6:1047-65. [DOI: 10.4155/fmc.14.58] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
12 Milger K, Holdt LM, Teupser D, Huber RM, Behr J, Kneidinger N. Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe bronchiectasis and pulmonary embolism. Int J Chron Obstruct Pulmon Dis 2015;10:891-7. [PMID: 26005342 DOI: 10.2147/COPD.S80173] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
13 Craig TJ, Henao MP. Advances in managing COPD related to α1 -antitrypsin deficiency: An under-recognized genetic disorder. Allergy 2018;73:2110-21. [PMID: 29984428 DOI: 10.1111/all.13558] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
14 Bergin DA, Hurley K, McElvaney NG, Reeves EP. Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent. Arch Immunol Ther Exp (Warsz). 2012;60:81-97. [PMID: 22349104 DOI: 10.1007/s00005-012-0162-5] [Cited by in Crossref: 80] [Cited by in F6Publishing: 68] [Article Influence: 8.9] [Reference Citation Analysis]
15 Qian DH, Shen BY, Zhan X, Peng C, Cheng D. Liquefying panniculitis associated with intraductal papillary mucinous neoplasm. JRSM Short Rep 2011;2:38. [PMID: 21637399 DOI: 10.1258/shorts.2011.010141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
16 Subramanian S, Shahaf G, Ozeri E, Miller LM, Vandenbark AA, Lewis EC, Offner H. Sustained expression of circulating human alpha-1 antitrypsin reduces inflammation, increases CD4+FoxP3+ Treg cell population and prevents signs of experimental autoimmune encephalomyelitis in mice. Metab Brain Dis 2011;26:107-13. [PMID: 21437674 DOI: 10.1007/s11011-011-9239-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
17 Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, Köhnlein T, Welte T. The discovery of α1-antitrypsin and its role in health and disease. Respir Med 2011;105:1129-39. [PMID: 21367592 DOI: 10.1016/j.rmed.2011.02.002] [Cited by in Crossref: 179] [Cited by in F6Publishing: 147] [Article Influence: 17.9] [Reference Citation Analysis]
18 Lopes AP, Mineiro MA, Costa F, Gomes J, Santos C, Antunes C, Maia D, Melo R, Canotilho M, Magalhães E, Vicente I, Valente C, Gonçalves BG, Conde B, Guimarães C, Sousa C, Amado J, Brandão ME, Sucena M, Oliveira MJ, Seixas S, Teixeira V, Telo L. Portuguese consensus document for the management of alpha-1-antitrypsin deficiency. Pulmonology 2018;24 Suppl 1:1-21. [PMID: 30473034 DOI: 10.1016/j.pulmoe.2018.09.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
19 Lomas DA. An ECLIPSE View of Alpha-1 Antitrypsin Deficiency. Ann Am Thorac Soc 2016;13 Suppl 4:S326-31. [PMID: 27564668 DOI: 10.1513/AnnalsATS.201506-348KV] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.7] [Reference Citation Analysis]
20 Dickens JA, Lomas DA. Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis. Drug Des Devel Ther 2011;5:391-405. [PMID: 21966212 DOI: 10.2147/DDDT.S14018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
21 Sabbagh DK, Barmayehvar B, Nguyen T, Edgar RG, Turner AM. Managing panniculitis in alpha-1 antitrypsin deficiency: Systematic review of evidence behind treatment. WJD 2018;7:1-8. [DOI: 10.5314/wjd.v7.i1.1] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
22 Franciosi AN, Ralph J, O'Farrell NJ, Buckley C, Gulmann C, O'Kane M, Carroll TP, McElvaney NG. Alpha-1 antitrypsin deficiency-associated panniculitis. J Am Acad Dermatol 2021:S0190-9622(21)00232-2. [PMID: 33516773 DOI: 10.1016/j.jaad.2021.01.074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Lomas DA. Twenty Years of Polymers: A Personal Perspective on Alpha-1 Antitrypsin Deficiency. COPD: Journal of Chronic Obstructive Pulmonary Disease 2013;10:17-25. [DOI: 10.3109/15412555.2013.764401] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
24 Ekeowa UI, Marciniak SJ, Lomas DA. α(1)-antitrypsin deficiency and inflammation. Expert Rev Clin Immunol 2011;7:243-52. [PMID: 21426261 DOI: 10.1586/eci.10.95] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
25 Dokai M, Madoiwa S, Yasumoto A, Kashiwakura Y, Ishiwata A, Sakata A, Makino N, Ohmori T, Mimuro J, Sakata Y. Local regulation of neutrophil elastase activity by endogenous α1-antitrypsin in lipopolysaccharide-primed hematological cells. Thromb Res 2011;128:283-92. [PMID: 21624645 DOI: 10.1016/j.thromres.2011.04.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
26 Rahaghi FF, Miravitlles M. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence. Respir Res 2017;18:105. [PMID: 28558837 DOI: 10.1186/s12931-017-0574-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
27 Lyon MJ. Metabolic panniculitis: alpha-1 antitrypsin deficiency panniculitis and pancreatic panniculitis. Dermatol Ther. 2010;23:368-374. [PMID: 20666824 DOI: 10.1111/j.1529-8019.2010.01337.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
28 Eckhard M, Kröll K, Karrasch T, Roller F, Feek U, Lange U, Noethe M, Seeger W, Ghofrani S, Schäffler A. Pannikulitis des Oberschenkels und Lungenemphysem bei einem 54-jährigen Patienten. Internist 2015;56:696-701. [DOI: 10.1007/s00108-015-3710-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
29 Sandhaus RA, Turino G, Brantly ML, Campos M, Cross CE, Goodman K, Hogarth DK, Knight SL, Stocks JM, Stoller JK, Strange C, Teckman J. The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult. Chronic Obstr Pulm Dis 2016;3:668-82. [PMID: 28848891 DOI: 10.15326/jcopdf.3.3.2015.0182] [Cited by in Crossref: 40] [Cited by in F6Publishing: 48] [Article Influence: 8.0] [Reference Citation Analysis]
30 Tan L, Perez J, Mela M, Miranda E, Burling KA, Rouhani FN, DeMeo DL, Haq I, Irving JA, Ordóñez A, Dickens JA, Brantly M, Marciniak SJ, Alexander GJ, Gooptu B, Lomas DA. Characterising the association of latency with α(1)-antitrypsin polymerisation using a novel monoclonal antibody. Int J Biochem Cell Biol 2015;58:81-91. [PMID: 25462157 DOI: 10.1016/j.biocel.2014.11.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
31 Chorostowska-Wynimko J, Barrecheguren M, Ferrarotti I, Greulich T, Sandhaus RA, Campos M. New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency. Int J Chron Obstruct Pulmon Dis 2020;15:345-55. [PMID: 32103933 DOI: 10.2147/COPD.S234646] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
32 Hazari YM, Bashir A, Habib M, Bashir S, Habib H, Qasim MA, Shah NN, Haq E, Teckman J, Fazili KM. Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions. Mutat Res. 2017;773:14-25. [PMID: 28927525 DOI: 10.1016/j.mrrev.2017.03.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
33 Blanco I, Lipsker D, Lara B, Janciauskiene S. Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: an update. Br J Dermatol 2016;174:753-62. [DOI: 10.1111/bjd.14309] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]